Page last updated: 2024-09-05

lu 135252 and Uremia

lu 135252 has been researched along with Uremia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brochu, E; Grose, JH; Kingma, I; Lacasse, S; Larivière, R; Lebel, M; Moreau, C1
Amann, K; Balajew, V; Hergenröder, S; Mall, G; Münter, K; Ritz, E; Wagner, J; Wessels, S1

Other Studies

2 other study(ies) available for lu 135252 and Uremia

ArticleYear
Endothelin ET(A) receptor blockade prevents the progression of renal failure and hypertension in uraemic rats.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1999, Volume: 14, Issue:8

    Topics: Animals; Disease Progression; Endothelin Receptor Antagonists; Endothelin-1; Hypertension; Kidney; Kidney Failure, Chronic; Male; Osmolar Concentration; Phenylpropionates; Pyrimidines; Rats; Rats, Wistar; Receptor, Endothelin A; Receptors, Endothelin; Uremia

1999
Endothelin A receptor blockade prevents capillary/myocyte mismatch in the heart of uremic animals.
    Journal of the American Society of Nephrology : JASN, 2000, Volume: 11, Issue:9

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Capillaries; Coronary Circulation; Endothelin Receptor Antagonists; Endothelin-1; Immunohistochemistry; In Situ Hybridization; Indoles; Male; Molecular Biology; Myocardium; Nephrectomy; Phenylpropionates; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; RNA, Messenger; Uremia

2000